ProNAi Therapeutics Inc. (DNAI) Plunged After Development Of PNT2258 Suspended

ProNAi Therapeutics Inc. (DNAI) announced Monday morning that, due to interim analysis of its Phase 2 trial of PNT2258, its has decided to suspend development of the drug.

from RTT - Before the Bell http://ift.tt/1TXm2Cd
via IFTTT